Trial initiated at Fudan University Shanghai Cancer Center (FUSCC) under the leadership of Leading Principal Investigator ...
Thousands of biting Asian ladybirds are swarming across the UK as the weather turns colder, with some homeowners finding their properties covered in the invasive insects. The non-native harlequin ...
Nordica's Fibroid Care Centre has treated 1,000 women with fibroids and adenomyosis using a non-surgical technology called High-Intensity Focused Ultrasoun ...
Discover how MahaVastu's Industrial Vastu protocol revolutionizes factory productivity. This spatial management framework ...
Voceryq (doruxapapogene ralaplasmid and lalikinogene sifuplasmid) has been granted an accelerated approval by the FDA as a ...
UroGen Pharma stock falls 2.2% to $32.72 today. The first patient begins treatment in a Phase 1 study of UGN-501.
Many people are waiting for the day when blood glucose monitoring is included on the Apple Watch. According to Bloomberg ...
WT outcomes have improved substantially through progress in molecular diagnosis, chemotherapy, radiotherapy, and surgery. Yet ...
Market is driven by food quality monitoring, environmental sensing, and growing demand for rapid odor detection.
<?xml encoding="utf-8" ?> Bioventus BVS reported third-quarter financial results on Monday. The transcript from the company’s ...
First plaque tool with prospective outcomes data. Faster, sustained LDL-C control: approximately 50% of patients reached goal by 90 days vs. approximately 35% with CCTA alone.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results